The Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States

Abstract

Fibromyalgia subjects were characterized by the greatest disease burden with more comorbidities and pain-related medications, poorer health status, function, sleep, lower productivity, and higher costs.

Humanistic and economic burden of fibromyalgia in Japan

“…The findings likewise aligned with previous studies highlighting the health and economic burden of fibromyalgia, although not specific to the Japanese population. In particular, fibromyalgia has been associated with multiple comorbidities,4 as well as decreases in most aspects of HRQoL 8. Moreover, high direct costs, due to health care resource use, and indirect costs, due to unemployment and work productivity loss, have been ascribed to fibromyalgia 8,9,11,12…”

“…Among Portuguese women, fibromyalgia was negatively associated with all dimensions of HRQoL, and the largest decreases were observed for physical functioning, physical role functioning, and general health 7. US adults (aged ≥18 years) diagnosed with fibromyalgia reported poorer sleep quality and health status, as well as more severe pain, than those with or without chronic pain 8. Another study on US adults (aged 18–65 years) demonstrated that severity has an impact on degree of burden; those with severe fibromyalgia self-reported greater pain intensity and fatigue, with poorer sleep quality, HRQoL, and mental health (anxiety and depression), than those with either moderate or mild fibromyalgia 9.…”

Gray matter abnormalities associated with fibromyalgia: A meta-analysis of voxel-based morphometric studies

“…Fibromyalgia is a relatively common condition with an estimated prevalence of 2.7% in the general population worldwide [3], causing substantial health, economic, and social burden [4]. At present, the diagnosis of fibromyalgia is mainly based on clinical symptoms and no unbiased biomarkers that can confirm it are known [1,2,5,6].…”

Eficacia analgésica del tratamiento invasivo miofascial (punción seca) en fibromialgia

“…UU se considera que afecta a 100 millones de individuos. Esta situación genera un coste de 560 a 635 billones de dólares anuales entre costes directos e indirectos (28), entre los que se destacan los gastos médicos directos, la pérdida de ingresos, la pérdida de productividad, los pagos por compensación y los gastos por servicios legales.…”

“…Auqnue el gasto sanitario derivado de la FM es mucho mayor en comparación con otros cuadros de dolor crónico, este elevado gasto no revierte en una mejoría en el estado de salud de los pacientes (28). Esta situación posiblemente es debida a las numerosas enfermedades concomitantes asociadas a la FM según relatan algunos textos científicos (30,31).…”